Key result
The PREFER study is a rationale and design paper for a randomized trial evaluating integrated palliative and heart failure care on symptom burden and quality of life, with no results reported yet.
Why the study?
Does integrated palliative advanced homecare and heart failure care improve symptom burden, quality of life, and activities of daily living in optimally treated outpatients with severe chronic heart failure compared to usual care?
RCT
PROBE (Open-label, blinded endpoint)
Randomized
Does integrated palliative advanced homecare and heart failure care improve symptom burden, quality of life, and activities of daily living in optimally treated outpatients with severe chronic heart failure compared to usual care?
The PREFER study is designed to evaluate whether integrating palliative homecare with active heart failure treatment improves symptom burden and quality of life in patients with severe chronic heart failure.
BACKGROUND: Guidelines have concluded that there is a great need for new models of integrated care, e.g., heart failure and palliative care, in order to facilitate equality of care for dying patients, regardless of diagnosis. We found no evidence in the literature concerning the advantages and effects of integrated heart failure and palliative advanced home care for patients with severe chronic heart failure. AIM: The primary aim is to study the effects of integrated Palliative advanced homecarRE and heart FailurE caRE (PREFER) on patients' symptom burden, quality of life, and activities of daily living (ADL) as compared to usual care. METHOD: Prospective, randomized study with an open-evaluation PROBE design. Optimally treated outpatients with chronic heart failure of varying aetiologies in New York Heart Association classes III-IV will be eligible to participate. CONCLUSION: The PREFER study is designed to investigate whether a new concept of managing patients with severe chronic heart failure by integrating palliative homecare and active heart failure treatment will reduce symptom burden, increase quality of life and ADL, and reduce the number of hospitalizations in patients with severe chronic heart failure.
No takes yet. Share an insight, caveat, or question.
Brännström et al. (2012) conducted an RCT in Severe chronic heart failure. Integrated Palliative advanced homecare and heart failure care (PREFER) vs. Usual care was evaluated on Symptom burden, quality of life, and activities of daily living (ADL). The PREFER study is a rationale and design paper for a randomized trial evaluating integrated palliative and heart failure care on symptom burden and quality of life, with no results reported yet.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: